Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, U.S.A.
School of Medicine, University of Toronto, Toronto, ON, Canada.
Anticancer Res. 2022 Jan;42(1):105-108. doi: 10.21873/anticanres.15463.
BACKGROUND/AIM: Dermat of ibrosarcoma protuberans (DFSP) is a soft-tissue sarcoma with a high risk of local recurrence, though typically never metastasizes. DFSP can transform into high-grade fibrosarcoma (DFSP-FS), which has a risk of metastasis. Currently, treatment for DFSP includes Moh's micrographic surgery (MMS); however, this is not recommended for DFSP-FS. Often, the transformation to DFSP-FS is not recognized until the final histological diagnosis. At that point, wide local excision (WLE) of a previous MMS site can be morbid. As such, we analyzed patient risk factors to allow identification of DFSP-FS transformation at presentation.
We reviewed 368 (174 female, 194 male) patients with a mean age of 42 years from two sarcoma centers. A total of 319 (87%) patients had a history of DFSP and 49 (13%) had DFSP-FS.
When comparing patients with a DFSP to those with a DFSP-FS, patients with a DFSP-FS were more likely (p<0.05) to be older, female and with larger tumors. A painful mass and rapidly enlarging mass were associated with DFSP-FS.
Patients who presented with DFSP-FS were found to typically have a larger, painful, and growing mass. Patients with these features should be referred for WLE over MMS at presentation.
背景/目的:隆突性皮肤纤维肉瘤(DFSP)是一种软组织肉瘤,局部复发风险高,但通常不会转移。DFSP 可转化为高级别纤维肉瘤(DFSP-FS),后者有转移的风险。目前,DFSP 的治疗包括 Mohs 显微外科手术(MMS);然而,DFSP-FS 不建议使用 MMS。通常,DFSP-FS 的转化直到最终的组织学诊断才被认识到。此时,之前 MMS 部位的广泛局部切除(WLE)可能会很棘手。因此,我们分析了患者的风险因素,以便在出现时识别 DFSP-FS 的转化。
我们回顾了来自两个肉瘤中心的 368 名(174 名女性,194 名男性)平均年龄为 42 岁的患者。共有 319 名(87%)患者有 DFSP 病史,49 名(13%)患者有 DFSP-FS。
在比较有 DFSP 的患者和有 DFSP-FS 的患者时,有 DFSP-FS 的患者更有可能(p<0.05)年龄较大、女性和肿瘤较大。疼痛性肿块和快速增大的肿块与 DFSP-FS 相关。
有 DFSP-FS 的患者通常表现为更大、疼痛和生长的肿块。具有这些特征的患者应在就诊时转诊进行 WLE 而不是 MMS。